JP Morgan Chase’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.98M | Sell |
10,000
-26,900
| -73% | -$7.99M | ﹤0.01% | 3786 |
|
|
2025
Q4 | $10.1M | Hold |
36,900
| – | – | ﹤0.01% | 2679 |
|
|
2025
Q3 | $9.97M | Sell |
36,900
-1,800
| -5% | -$490K | ﹤0.01% | 2716 |
|
|
2025
Q2 | $10.7M | Buy |
38,700
+21,800
| +129% | +$5.93M | ﹤0.01% | 2495 |
|
|
2025
Q1 | $4.48M | Sell |
16,900
-44,100
| -72% | -$10.9M | ﹤0.01% | 3251 |
|
|
2024
Q4 | $14.2M | Sell |
61,000
-85,000
| -58% | -$19.5M | ﹤0.01% | 2373 |
|
|
2024
Q3 | $32.2M | Sell |
146,000
-220,100
| -60% | -$45.5M | ﹤0.01% | 1619 |
|
|
2024
Q2 | $72M | Buy |
366,100
+327,100
| +839% | +$67.6M | 0.01% | 1075 |
|
|
2024
Q1 | $8.4M | Sell |
39,000
-55,700
| -59% | -$11.7M | ﹤0.01% | 2640 |
|
|
2023
Q4 | $19.9M | Buy |
94,700
+10,700
| +13% | +$2.28M | ﹤0.01% | 1862 |
|
|
2023
Q3 | $16.8M | Buy |
84,000
+34,100
| +68% | +$6.78M | ﹤0.01% | 1823 |
|
|
2023
Q2 | $9.25M | Sell |
49,900
-15,400
| -24% | -$2.85M | ﹤0.01% | 2356 |
|
|
2023
Q1 | $12.5M | Buy |
65,300
+22,400
| +52% | +$4.05M | ﹤0.01% | 2072 |
|
|
2022
Q4 | $7.21M | Sell |
42,900
-10,200
| -19% | -$1.77M | ﹤0.01% | 2538 |
|
|
2022
Q3 | $9.41M | Buy |
53,100
+37,300
| +236% | +$7.37M | ﹤0.01% | 2196 |
|
|
2022
Q2 | $3.23M | Sell |
15,800
-18,800
| -54% | -$3.98M | ﹤0.01% | 3155 |
|
|
2022
Q1 | $8.23M | Sell |
34,600
-20,200
| -37% | -$4.74M | ﹤0.01% | 2568 |
|
|
2021
Q4 | $12.5M | Sell |
54,800
-125,000
| -70% | -$27.5M | ﹤0.01% | 2247 |
|
|
2021
Q3 | $34.8M | Sell |
179,800
-58,400
| -25% | -$11.8M | ﹤0.01% | 1382 |
|
|
2021
Q2 | $50.7M | Buy |
238,200
+22,100
| +10% | +$4.67M | 0.01% | 1214 |
|
|
2021
Q1 | $44.1M | Buy |
216,100
+183,400
| +561% | +$36.1M | 0.01% | 1215 |
|
|
2020
Q4 | $5.95M | Hold |
32,700
| – | – | ﹤0.01% | 2649 |
|
|
2020
Q3 | $5.43M | Hold |
32,700
| – | – | ﹤0.01% | 2501 |
|
|
2020
Q2 | $5.32M | Sell |
32,700
-90,000
| -73% | -$16.1M | ﹤0.01% | 2408 |
|
|
2020
Q1 | $21.2M | Buy |
122,700
+96,900
| +376% | +$19.3M | 0.01% | 1218 |
|
|
2019
Q4 | $5.18M | Hold |
25,800
| – | – | ﹤0.01% | 2645 |
|
|
2019
Q3 | $5.45M | Hold |
25,800
| – | – | ﹤0.01% | 2634 |
|
|
2019
Q2 | $5M | Hold |
25,800
| – | – | ﹤0.01% | 2656 |
|
|
2019
Q1 | $4.25M | Sell |
25,800
-55,000
| -68% | -$9.72M | ﹤0.01% | 2716 |
|
|
2018
Q4 | $15.2M | Hold |
80,800
| – | – | ﹤0.01% | 1692 |
|
|
2018
Q3 | $13.8M | Buy |
80,800
+14,800
| +22% | +$2.49M | ﹤0.01% | 1945 |
|
|
2018
Q2 | $10.8M | Buy |
66,000
+11,000
| +20% | +$1.8M | ﹤0.01% | 2078 |
|
|
2018
Q1 | $8.9M | Hold |
55,000
| – | – | ﹤0.01% | 2113 |
|
|
2017
Q4 | $8.03M | Buy |
+55,000
| New | +$7.83M | ﹤0.01% | 2297 |
|
|
2017
Q2 | – | Sell |
-22,200
| Closed | -$2.64M | – | 4981 |
|
|
2017
Q1 | $2.64M | Hold |
22,200
| – | – | ﹤0.01% | 2867 |
|
|
2016
Q4 | $2.56M | Buy |
+22,200
| New | +$2.47M | ﹤0.01% | 2912 |
|
|
2014
Q4 | – | Sell |
-11,500
| Closed | -$919K | – | 4231 |
|
|
2014
Q3 | $919K | Buy |
+11,500
| New | +$867K | ﹤0.01% | 3386 |
|
Other funds holding CME
VCM
VPM
JP Morgan Chase's CME Position: Q1 2026 in Review
JP Morgan Chase increased its CME Group (CME) stake by 10% in Q1 2026, buying an estimated $329M and bringing the position to 12,209,761 shares worth $3.63B. The position accounts for 0.23% of the portfolio, ranked #93.
JP Morgan Chase first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- JP Morgan Chase held 12,209,761 shares of CME Group worth $3.63B as of Q1 2026.
- JP Morgan Chase bought 1,108,304 CME Group shares in Q1 2026, an estimated $329M.
- CME Group made up 0.23% of JP Morgan Chase's portfolio in Q1 2026, its #93 holding.
- JP Morgan Chase first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.